the 26th congress of the scandinavian society of anaesthesiology and intensive care medicine, tromso, norway, 13-17 june 2001第26届国会的北欧社会麻醉学和重症监护医学,特罗姆瑟,挪威,2001年6月.pdfVIP

Critical Care August 2001 Vol 5 No 4 Investigational Drugs database Meeting report The 26th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Tromso, Norway, 13–17 June 2001 Investigational Drugs database , Current Drugs Ltd, London, UK Correspondence: Investigational Drugs database, info@ Published online: 13 July 2001 Critical Care 2001, 5:204–206 © 2001 Current Drugs Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X) Abstract The 26th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine took place in the state-of-the art Tromso University Hospital. There were over 500 participants, and approximately 300 oral and poster presentations highlighted the latest progress in diverse areas. Much interest focused on activated protein C (APC) and other ways forward in sepsis treatment, pain management, novel markers of neurotrauma and antioxidants in bypass surgery. The meeting continues to be the leading anaesthesiology and intensive care conference in the region. Keywords anesthesiology, congresses, intensive care, pain, sepsis The Congress took place at the northernmost academic aspects of sepsis and septic shock. This interest stems center in the world, in the state-of-the art Tromso University partly from the recent results of a multicenter trial that Hospital. There were over 500 participants, mainly from demonstrated the beneficial effects and a significant sur- Scandinavian countries, with approximately 50 invited par- vival benefit provided by APC infusion in septic patients. ticipants from non-Scandinavian countries, primarily from